MedAdvisor Says Potential Divestment of its Australia-New Zealand Business Carries AU$35 Million Price Tag, Shares Fall 28%

MT Newswires Live

May 09, 2025

MedAdvisor (ASX:MDR) said that the proposed acquisition of 100% of MedAdvisor International and its subsidiaries and all intellectual property carries a headline price of AU$35 million, according to a Friday Australian bourse filing.

MedAdvisor International conducts the firm's Australia and New Zealand business.

An uncapped contingent consideration comprised of a three-year earn-out based on performance will also be available.

It granted the acquirer an exclusive right to conduct due diligence on the business and negotiate formal sale documentation in line with the letter of intent for around five weeks, with the ability to extend for a further two weeks.

Assuming due diligence and negotiations proceed positively, the timeframe for the execution of a binding sale agreement is expected to be around June 30.

Its shares plummeted 28% in recent trading on Friday.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2534144397"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2534144397\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2534144397?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-05-09 13:23","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2534144397","market":"sh","top_or_hot":-1,"title":"MedAdvisor Says Potential Divestment of its Australia-New Zealand Business Carries AU$35 Million Price Tag, Shares Fall 28%","media":"MT Newswires Live","content":"<html><body><p> MedAdvisor (ASX:MDR) said that the proposed acquisition of 100% of MedAdvisor International and its subsidiaries and all intellectual property carries a headline price of AU$35 million, according to a Friday Australian bourse filing.</p><p>MedAdvisor International conducts the firm's Australia and New Zealand business.</p><p>An uncapped contingent consideration comprised of a three-year earn-out based on performance will also be available.</p><p>It granted the acquirer an exclusive right to conduct due diligence on the business and negotiate formal sale documentation in line with the letter of intent for around five weeks, with the ability to extend for a further two weeks.</p><p>Assuming due diligence and negotiations proceed positively, the timeframe for the execution of a binding sale agreement is expected to be around June 30.</p><p>Its shares plummeted 28% in recent trading on Friday.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>MedAdvisor Says Potential Divestment of its Australia-New Zealand Business Carries AU$35 Million Price Tag, Shares Fall 28%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMedAdvisor Says Potential Divestment of its Australia-New Zealand Business Carries AU$35 Million Price Tag, Shares Fall 28%\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2025-05-09 13:23</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> MedAdvisor (ASX:MDR) said that the proposed acquisition of 100% of MedAdvisor International and its subsidiaries and all intellectual property carries a headline price of AU$35 million, according to a Friday Australian bourse filing.</p><p>MedAdvisor International conducts the firm's Australia and New Zealand business.</p><p>An uncapped contingent consideration comprised of a three-year earn-out based on performance will also be available.</p><p>It granted the acquirer an exclusive right to conduct due diligence on the business and negotiate formal sale documentation in line with the letter of intent for around five weeks, with the ability to extend for a further two weeks.</p><p>Assuming due diligence and negotiations proceed positively, the timeframe for the execution of a binding sale agreement is expected to be around June 30.</p><p>Its shares plummeted 28% in recent trading on Friday.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"XJO.AU","symbol_name":"标普/澳交所 200指数","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2534144397","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2534144397","pubTimestamp":1746768233,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"MedAdvisor  said that the proposed acquisition of 100% of MedAdvisor International and its subsidiaries and all intellectual property carries a headline price of AU$35 million, according to a Friday Australian bourse filing.MedAdvisor International conducts the firm's Australia and New Zealand business.An uncapped contingent consideration comprised of a three-year earn-out based on performance will also be available.It granted the acquirer an exclusive right to conduct due diligence on the business and negotiate formal sale documentation in line with the letter of intent for around five weeks, with the ability to extend for a further two weeks.Assuming due diligence and negotiations proceed positively, the timeframe for the execution of a binding sale agreement is expected to be around June 30.Its shares plummeted 28% in recent trading on Friday.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"XJO.AU":"标普/澳交所 200指数","XKO.AU":"标普/澳交所 300指数","T10G.NZ":"S&P/NZX 10","NZ50G.NZ":"S&P/NZX 50","BK7094":"医疗保健技术","NZ20C.NZ":"S&P/NZX 20","XAO.AU":"标普/澳交所 普通股指数"},"translate_title":"MedAdvisor表示可能剥离其澳大利亚-新西兰业务的价格为3500万澳元，股价下跌28%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"T10G.NZ":1,"MDR.AU":0.9,"XKO.AU":1,"XJO.AU":1,"NZ50G.NZ":1,"NZ20C.NZ":1,"XAO.AU":1},"content_text":"MedAdvisor (ASX:MDR) said that the proposed acquisition of 100% of MedAdvisor International and its subsidiaries and all intellectual property carries a headline price of AU$35 million, according to a Friday Australian bourse filing.MedAdvisor International conducts the firm's Australia and New Zealand business.An uncapped contingent consideration comprised of a three-year earn-out based on performance will also be available.It granted the acquirer an exclusive right to conduct due diligence on the business and negotiate formal sale documentation in line with the letter of intent for around five weeks, with the ability to extend for a further two weeks.Assuming due diligence and negotiations proceed positively, the timeframe for the execution of a binding sale agreement is expected to be around June 30.Its shares plummeted 28% in recent trading on Friday.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-2","news_tag":"shareholding","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}